Elevance Health Q2 EPS Forecast Reduced by Zacks Research
Elevance Health, Inc. (NYSE:ELV – Free Report) – Research analysts at Zacks Research dropped their Q2 2026 earnings estimates for Elevance Health in a research report issued on Wednesday, May 6th. Zacks Research analyst Team now expects that the company will post earnings per share of $6.15 for the quarter, down from their previous estimate […]
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
